Literature DB >> 8608653

Production of IL-6 by T cells from the femoral head of patients with rapidly destructive coxopathy (RDC).

M Tamai1, K Sagawa, R Kawabata, A Inoue, K Itoh.   

Abstract

RDC is a syndrome with unknown etiology that causes rapid destruction of a hip joint. We have investigated the production of osteoclast-activating cytokines (IL-6, IL-1alpha and tumour necrosis factor-alpha (TNF-alpha)), interferon-gamma (IFN-gamma) and IL-8 by T cells in the affected joint. The level of IL-6 produced by the T cell lines (TCL) established from the femoral head was significantly higher than that from patients' or healthy donors' peripheral blood mononuclear cells (PBMC). IL-6 production by the TCL from synovial membrane or from patients' PBMC was also significantly higher than that from healthy donors' PBMC. IL-1alpha production by the TCL from the femoral head was significantly higher than any of the other groups when all the TCL were used for the analysis. TNF-alpha production was highest in the TCL from patients' PBMC. The levels of IFN-gamma or IL-8 were not significantly different among these four groups. The plasma levels of all these cytokines except for IFN-gamma, that was rather lower, in RDC patients were not significantly different from those in osteoarthrosis or trauma patients, or healthy donors. These results suggest that T cells at the affected femoral head, and also synovial membrane to some extent, are involved in bone resorption through the production of IL-6 and probably IL-1alpha in patients with RDC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8608653      PMCID: PMC2200375          DOI: 10.1111/j.1365-2249.1996.tb08309.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro.

Authors:  M Gowen; G R Mundy
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

2.  Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta.

Authors:  F E Dewhirst; P P Stashenko; J E Mole; T Tsurumachi
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

3.  Phenotypic and functional characterization of human T cell clones.

Authors:  S S Patel; A D Duby; D L Thiele; P E Lipsky
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

4.  Interleukin 6 is involved in interleukin 1-induced activities.

Authors:  M Helle; J P Brakenhoff; E R De Groot; L A Aarden
Journal:  Eur J Immunol       Date:  1988-06       Impact factor: 5.532

5.  Experimental study on immunological reactions against the articular cartilage.

Authors:  Y Yoshioka; S Tsuru; M Yokoyama; K Nomoto
Journal:  Int Arch Allergy Appl Immunol       Date:  1982

6.  IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release.

Authors:  N Kurihara; D Bertolini; T Suda; Y Akiyama; G D Roodman
Journal:  J Immunol       Date:  1990-06-01       Impact factor: 5.422

7.  Idiopathic chondrolysis--an immunopathologic study.

Authors:  J H Herman; E B Herzig; J D Crissman; M V Dennis; E V Hess
Journal:  J Rheumatol       Date:  1980 Sep-Oct       Impact factor: 4.666

8.  Recombinant human interleukin 1 alpha: purification and biological characterization.

Authors:  U Gubler; A O Chua; A S Stern; C P Hellmann; M P Vitek; T M DeChiara; W R Benjamin; K J Collier; M Dukovich; P C Familletti
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

9.  Clonal analysis of functionally distinct human CD4+ T cell subsets.

Authors:  F T Rotteveel; I Kokkelink; R A van Lier; B Kuenen; A Meager; F Miedema; C J Lucas
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

10.  Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

Authors:  K Itoh; C D Platsoucas; C M Balch
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  6 in total

1.  Mature and activated osteoclasts exist in the synovium of rapidly destructive coxarthrosis.

Authors:  Kenji Ogawa; Masaaki Mawatari; Mitsunori Komine; Masamori Shigematsu; Masaru Kitajima; Akiko Kukita; Takao Hotokebuchi
Journal:  J Bone Miner Metab       Date:  2007-10-25       Impact factor: 2.626

2.  Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures.

Authors:  C Menaa; R D Devlin; S V Reddy; Y Gazitt; S J Choi; G D Roodman
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

3.  Bone turnover markers in the early stage of rapidly progressive osteoarthritis of the hip.

Authors:  Tadashi Yasuda; Kazuhiro Matsunaga; Takumi Hashimura; Yoshihiro Tsukamoto; Tatsuya Sueyoshi; Satoshi Ota; Satoshi Fujita; Eijiro Onishi
Journal:  Eur J Rheumatol       Date:  2020-09-03

4.  Rapidly destructive osteoarthritis can mimic infection.

Authors:  Gavin Hart; Thomas Fehring
Journal:  Arthroplast Today       Date:  2016-01-09

5.  Clinico-radiological diagnosis and grading of rapidly progressive osteoarthritis of the hip.

Authors:  Ancuţa Zazgyva; Simona Gurzu; István Gergely; Ioan Jung; Ciprian O Roman; Tudor S Pop
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  Rapidly destructive osteoarthritis of the hip joint: a case series.

Authors:  Sameer Batra; Meenakshi Batra; A McMurtrie; A K Sinha
Journal:  J Orthop Surg Res       Date:  2008-01-11       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.